Previous Close | 0.9200 |
Open | 0.9200 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.9200 - 0.9200 |
52 Week Range | 0.6720 - 2.2200 |
Volume | |
Avg. Volume | 950 |
Market Cap | 7.911M |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4900 |
Earnings Date | Mar 29, 2024 - Apr 02, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for BICX
ANAHEIM, CA - (NewMediaWire) - February 28, 2024 - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance use and related disorders, announced that its subsidiary BioCorRx Pharmaceuticals ...
ANAHEIM, CA - (NewMediaWire) - February 8, 2024 - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders, announced that its subsidiary BioCorRx Pharmaceuticals...
ANAHEIM, CA - (NewMediaWire) - January 09, 2024 - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders, announced the appointment of Louis Lucido as Interim P...